CRISPR Therapeutics AG (CRSP)

USD 41.06

(-8.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.22 Billion 2.24 Billion 2.75 Billion 1.82 Billion 1.06 Billion 489.01 Million
Total Current Assets 1.9 Billion 1.85 Billion 2.41 Billion 1.71 Billion 987.54 Million 466.39 Million
Cash And Short Term Investments 1.69 Billion 1.81 Billion 2.37 Billion 1.69 Billion 943.77 Million 456.64 Million
Cash and Cash Equivalents 389.47 Million 211.88 Million 923.03 Million 1.16 Billion 943.77 Million 456.64 Million
Short Term Investments 1.3 Billion 1.6 Billion 1.45 Billion 521.71 Million - -
Net Receivables 200 Million 11.2 Million 305 Thousand 144 Thousand 99 Thousand 88 Thousand
Inventory - -11.2 Million - - 1.00 1.00
Other Current Assets 14.38 Million 37.7 Million 38.07 Million 26.14 Million 43.67 Million 9.65 Million
Total Non-Current Assets 321.49 Million 390.03 Million 334.36 Million 111.34 Million 79.2 Million 22.62 Million
Net PPE 305.93 Million 320.55 Million 312.03 Million 93.02 Million 72.83 Million 18.5 Million
Good Will And Intangible Assets 16 Thousand 71 Thousand 125 Thousand 180 Thousand 235 Thousand 289 Thousand
Good Will - - - - - -
Intangible Assets 16 Thousand 71 Thousand 125 Thousand 180 Thousand 235 Thousand 289 Thousand
Long-Term Investments 1.97 Million 53.13 Million 16.91 Million 16.84 Million 5.04 Million 3.16 Million
Tax Assets - - -16.91 Million -16.84 Million -5.04 Million -3.16 Million
Other Non Current Assets 13.56 Million 16.27 Million 22.2 Million 18.14 Million 6.13 Million 3.83 Million
Other Assets - - - - - -
Total Liabilities 346.76 Million 367.57 Million 352.41 Million 163.73 Million 127.32 Million 96.82 Million
Total Current Liabilities 108.79 Million 121.1 Million 119.88 Million 94.25 Million 57.1 Million 27.74 Million
Account Payables 38.14 Million 27.42 Million 14.81 Million 9.09 Million 5.94 Million 5.06 Million
Tax Payables 438 Thousand 135 Thousand 724 Thousand 10.47 Million 583 Thousand 402 Thousand
Short Term Debt 15.62 Million 15.84 Million 12.15 Million 11.36 Million 8.48 Million -35.32 Million
Deferred Revenue 4.1 Million 12.32 Million 1.01 Million 2.34 Million 960 Thousand 57.78 Million
Other Current Liabilities 50.91 Million 65.51 Million 91.89 Million 71.46 Million 41.71 Million 221 Thousand
Total Non Current Liabilities 237.97 Million 246.47 Million 232.53 Million 69.47 Million 70.22 Million 69.07 Million
Long-Term Debt 223 Million 228.17 Million 212.87 Million 50.06 Million 44.05 Million -
Deferred Revenue Non Current 14.01 Million 12.32 Million 12.32 Million 11.77 Million 11.77 Million 57.78 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 958 Thousand 5.96 Million 7.33 Million 7.63 Million 14.39 Million 11.29 Million
Other Liabilities - - - - - -
Total Equity 1.88 Billion 1.87 Billion 2.39 Billion 1.66 Billion 939.42 Million 392.19 Million
Stock Holders Equity 1.88 Billion 1.87 Billion 2.39 Billion 1.66 Billion 939.42 Million 392.19 Million
Common Stock 2.49 Million 2.44 Million 2.39 Million 2.27 Million 1.84 Million 1.58 Million
Retained Earnings -999.7 Million -846.09 Million -195.91 Million -573.57 Million -224.71 Million -291.56 Million
Accumulated other comprehensive income 1.91 Million -15.64 Million -5.06 Million -83 Thousand 7000.00 -8000.00
Common Stock Equity 1.88 Billion 1.87 Billion 2.39 Billion 1.66 Billion 939.42 Million 392.19 Million
Capital Lease Obligation 238.63 Million 244.02 Million 225.03 Million 61.42 Million 52.53 Million -
Total Investments 1.3 Billion 1.65 Billion 1.45 Billion 521.71 Million 5.04 Million 3.16 Million
Total Debt 238.63 Million 244.02 Million 225.03 Million 61.42 Million 52.53 Million -
Net Debt -150.84 Million 32.13 Million -698 Million -1.1 Billion -891.23 Million -456.64 Million

Balance Sheet Charts